• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(-)-α-红没药醇对 LPS 诱导的 RAW264.7 巨噬细胞炎症反应的抑制作用。

Inhibitory effects of (-)-α-bisabolol on LPS-induced inflammatory response in RAW264.7 macrophages.

机构信息

Biospectrum Life Science Institute, Eines Platz 11th FL, 442-13 Sangdaewon Dong, Seoungnam City, 462-807 Gyunggi Do, Republic of Korea.

出版信息

Food Chem Toxicol. 2011 Oct;49(10):2580-5. doi: 10.1016/j.fct.2011.06.076. Epub 2011 Jul 13.

DOI:10.1016/j.fct.2011.06.076
PMID:21771629
Abstract

Although (-)-α-bisabolol, a natural monocyclic sesquiterpene alcohol, is often used as a cosmetic soothing supplement, little is known about its mechanisms of anti-inflammatory effects. Therefore, this study was designed to investigate anti-inflammatory effects of (-)-α-bisabolol and its mechanisms of action. In this study, we found that (-)-α-bisabolol inhibited lipopolysaccharide (LPS)-induced production of nitric oxide (NO) and prostaglandin E(2) (PGE(2)) in RAW264.7 cells. In addition, expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) genes was reduced, as evidenced by Western blot and luciferase reporter assays for COX-2 and iNOS. To assess the mechanism of the anti-inflammatory property of (-)-α-bisabolol, its effects on the activity of AP-1 and NF-κB promoters were examined. LPS-induced activation of AP-1 and NF-κB promoters was significantly reduced by (-)-α-bisabolol. Consistently, (-)-α-bisabolol reduced LPS-induced phosphorylation of IκBα. In addition, while LPS-induced phosphorylation of ERK and p38 was attenuated by (-)-α-bisabolol, significant changes in the level of phosphorylated JNK were not observed. Our results indicate that (-)-α-bisabolol exerts anti-inflammatory effects by downregulating expression of iNOS and COX-2 genes through inhibition of NF-κB and AP-1 (ERK and p38) signaling.

摘要

虽然(-)-α- 倍半水芹醇是一种常用的天然单环倍半萜醇,常被用作化妆品的舒缓补充剂,但对其抗炎作用的机制知之甚少。因此,本研究旨在研究(-)-α- 倍半水芹醇的抗炎作用及其作用机制。在这项研究中,我们发现(-)-α- 倍半水芹醇抑制脂多糖(LPS)诱导的 RAW264.7 细胞中一氧化氮(NO)和前列腺素 E(2)(PGE(2))的产生。此外,通过 Western blot 和 COX-2 和 iNOS 的荧光素酶报告基因检测,发现环氧合酶-2(COX-2)和诱导型一氧化氮合酶(iNOS)基因的表达减少。为了评估(-)-α- 倍半水芹醇抗炎特性的机制,研究了其对 AP-1 和 NF-κB 启动子活性的影响。LPS 诱导的 AP-1 和 NF-κB 启动子的激活被(-)-α- 倍半水芹醇显著抑制。一致地,(-)-α- 倍半水芹醇减少了 LPS 诱导的 IκBα磷酸化。此外,虽然(-)-α- 倍半水芹醇减弱了 LPS 诱导的 ERK 和 p38 的磷酸化,但观察到磷酸化 JNK 的水平没有显著变化。我们的结果表明,(-)-α- 倍半水芹醇通过抑制 NF-κB 和 AP-1(ERK 和 p38)信号通路下调 iNOS 和 COX-2 基因的表达来发挥抗炎作用。

相似文献

1
Inhibitory effects of (-)-α-bisabolol on LPS-induced inflammatory response in RAW264.7 macrophages.(-)-α-红没药醇对 LPS 诱导的 RAW264.7 巨噬细胞炎症反应的抑制作用。
Food Chem Toxicol. 2011 Oct;49(10):2580-5. doi: 10.1016/j.fct.2011.06.076. Epub 2011 Jul 13.
2
Zedoarondiol isolated from the rhizoma of Curcuma heyneana is involved in the inhibition of iNOS, COX-2 and pro-inflammatory cytokines via the downregulation of NF-kappaB pathway in LPS-stimulated murine macrophages.莪术根茎中分离得到的莪术醇通过下调 LPS 刺激的小鼠巨噬细胞中 NF-κB 通路,参与抑制 iNOS、COX-2 和促炎细胞因子。
Int Immunopharmacol. 2009 Aug;9(9):1049-57. doi: 10.1016/j.intimp.2009.04.012. Epub 2009 Apr 24.
3
Anti-inflammatory activity of bark of Dioscorea batatas DECNE through the inhibition of iNOS and COX-2 expressions in RAW264.7 cells via NF-κB and ERK1/2 inactivation.黄药子通过抑制 RAW264.7 细胞中 NF-κB 和 ERK1/2 的活化来抑制 iNOS 和 COX-2 的表达,从而发挥抗炎活性。
Food Chem Toxicol. 2010 Nov;48(11):3073-9. doi: 10.1016/j.fct.2010.07.048. Epub 2010 Aug 4.
4
Quaternary alkaloid, pseudocoptisine isolated from tubers of Corydalis turtschaninovi inhibits LPS-induced nitric oxide, PGE(2), and pro-inflammatory cytokines production via the down-regulation of NF-kappaB in RAW 264.7 murine macrophage cells.从紫堇属植物块茎中分离得到的季铵型生物碱伪原小檗碱通过下调 RAW 264.7 鼠巨噬细胞细胞中的 NF-κB 抑制 LPS 诱导的一氧化氮、PGE(2)和促炎细胞因子的产生。
Int Immunopharmacol. 2009 Oct;9(11):1323-31. doi: 10.1016/j.intimp.2009.08.001. Epub 2009 Aug 7.
5
The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-kappaB regulation, in RAW264.7 cells.天然存在的双黄酮奥克萘黄酮可抑制RAW264.7细胞中脂多糖诱导的诱导型一氧化氮合酶(iNOS)表达,该表达由细胞外信号调节激酶1/2(ERK1/2)通过核因子κB(NF-κB)调控介导。
Arch Biochem Biophys. 2006 Mar 15;447(2):136-46. doi: 10.1016/j.abb.2006.01.016. Epub 2006 Feb 10.
6
Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation.4-甲氧基厚朴酚的抗炎活性是通过使核因子κB、应激活化蛋白激酶和p38丝裂原活化蛋白激酶失活来抑制RAW 264.7巨噬细胞中诱导型一氧化氮合酶和环氧化酶-2的表达的结果。
Eur J Pharmacol. 2008 May 31;586(1-3):340-9. doi: 10.1016/j.ejphar.2008.02.044. Epub 2008 Feb 26.
7
Inhibitory effect of Buthus martensi Karsch extracts on interleukin-1beta-induced expression of nitric oxide (NO) synthase and production of NO in human chondrocytes and LPS-induced NO and prostaglandin E2 production in mouse peritoneal macrophages.全蝎提取物对白细胞介素-1β诱导人软骨细胞中一氧化氮合酶表达及一氧化氮生成的抑制作用,以及对脂多糖诱导小鼠腹腔巨噬细胞中一氧化氮和前列腺素E2生成的抑制作用。
Toxicol In Vitro. 2005 Sep;19(6):757-69. doi: 10.1016/j.tiv.2005.04.008.
8
Flower extract of Panax notoginseng attenuates lipopolysaccharide-induced inflammatory response via blocking of NF-kappaB signaling pathway in murine macrophages.三七花提取物通过阻断小鼠巨噬细胞中的NF-κB信号通路减轻脂多糖诱导的炎症反应。
J Ethnopharmacol. 2009 Mar 18;122(2):313-9. doi: 10.1016/j.jep.2008.12.024. Epub 2008 Dec 27.
9
Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kappaB pathways.咖啡酸苯乙酯通过p38/ERK和NF-κB途径保护小鼠免受致死性内毒素休克,并抑制脂多糖诱导的RAW 264.7巨噬细胞中环氧合酶-2和诱导型一氧化氮合酶的表达。
Int J Biochem Cell Biol. 2008;40(11):2572-82. doi: 10.1016/j.biocel.2008.05.005. Epub 2008 May 15.
10
Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophages. flavokawain A 通过阻断 NF-κB 和 AP-1 激活抑制 RAW 264.7 巨噬细胞中 iNOS 和 COX-2 的表达。
Food Chem Toxicol. 2013 Aug;58:479-86. doi: 10.1016/j.fct.2013.05.031. Epub 2013 May 28.

引用本文的文献

1
α-Bisabolol, a Dietary Bioactive Terpene Attenuates Oxidative Stress and Inflammation in Colonic Mucosa of Acetic Acid-Induced Colitis in Rats.α-红没药醇,一种膳食生物活性萜烯,可减轻大鼠乙酸诱导性结肠炎结肠黏膜中的氧化应激和炎症。
Int J Mol Sci. 2025 Aug 22;26(17):8168. doi: 10.3390/ijms26178168.
2
Mining methods and typical structural mechanisms of terpene cyclases.萜烯环化酶的挖掘方法及典型结构机制
Bioresour Bioprocess. 2021 Jul 28;8(1):66. doi: 10.1186/s40643-021-00421-2.
3
Essential Oils: Repellency and Toxicity against Imported Fire Ants (Hymenoptera: Formicidae).
精油对红火蚁(膜翅目:蚁科)的驱避和毒性作用。
Molecules. 2023 Jul 22;28(14):5584. doi: 10.3390/molecules28145584.
4
Antagonism of cadmium-induced liver injury in ducks by α-bisabolol.α-红没药醇对镉诱导的鸭肝损伤的拮抗作用。
Front Vet Sci. 2022 Nov 7;9:1024549. doi: 10.3389/fvets.2022.1024549. eCollection 2022.
5
(-)-α-Bisabolol Alleviates Atopic Dermatitis by Inhibiting MAPK and NF-κB Signaling in Mast Cell.(-)-α- 红没药醇通过抑制肥大细胞中的 MAPK 和 NF-κB 信号通路缓解特应性皮炎。
Molecules. 2022 Jun 21;27(13):3985. doi: 10.3390/molecules27133985.
6
-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR- Transcription Factor: In Vivo and In Vitro Study.红没药醇通过刺激结肠PPAR-转录因子减轻结肠炎症:体内和体外研究
PPAR Res. 2022 Apr 13;2022:5498115. doi: 10.1155/2022/5498115. eCollection 2022.
7
Health Benefits, Pharmacological Effects, Molecular Mechanisms, and Therapeutic Potential of α-Bisabolol.α-红没药醇的健康益处、药理作用、分子机制和治疗潜力。
Nutrients. 2022 Mar 25;14(7):1370. doi: 10.3390/nu14071370.
8
Biotransformation of (-)-α-Bisabolol by .(-)-α- 姜烯醇的生物转化 。
Molecules. 2022 Jan 27;27(3):881. doi: 10.3390/molecules27030881.
9
In Vitro Anti-Inflammatory Activity of Essential Oil and β-Bisabolol Derived from Cotton Gin Trash.从轧花厂废料中提取的精油和 β- 态醇的体外抗炎活性。
Molecules. 2022 Jan 14;27(2):526. doi: 10.3390/molecules27020526.
10
Analgesic Potential of Terpenes Derived from .萜类化合物的镇痛潜力来自 。
Pharmacol Rev. 2021 Oct;73(4):98-126. doi: 10.1124/pharmrev.120.000046.